Narnolia

Narnolia

Toll Free No: 1800-103-7212

DR. REDDYS LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE2855.3538.95 (+1.38 %)
PREV CLOSE ( ) 2816.40
OPEN PRICE ( ) 2829.40
BID PRICE (QTY) 2855.35 (69)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 21804
TODAY'S LOW / HIGH ( )2813.10 2865.00
52 WK LOW / HIGH ( )1888 2875
NSE2859.4037.25 (+1.32 %)
PREV CLOSE( ) 2822.15
OPEN PRICE ( ) 2835.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2859.40 (371)
VOLUME 748185
TODAY'S LOW / HIGH( ) 2813.10 2875.00
52 WK LOW / HIGH ( )1872.95 2878
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 24-02 1984
Management Info
K Satish Reddy - Chairman GV Prasad - Managing Director
Registered Office

Address 8-2-337, Road No. 3,Banjara Hills,,
Hyderabad,
Telangana-500034

Phone 040 - 4900 2900

Email sureshvs@drreddys.com ; shares@drreddys.com

Website www.drreddys.com

Registrars Details
Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE, NSE, MCX, New York
NEWS
16Apr Dr. Reddys Lab, Majesco and Cipla to s
Dr. Reddys Laboratories has received the Establishment Inspection Report..
16Apr Dr. Reddys Lab receives EIR from USFDA
Dr. Reddys Laboratories has received the Establishment Inspection Report..
15Apr Dr. Reddy's Lab to acquire portfolio o
Dr. Reddy's Laboratories has entered into a definitive agreement to acqu..
02Apr Dr. Reddy’s Laboratories’ arm declares
Dr. Reddy’s Laboratories through its wholly owned subsidiary -- Promius..
02Apr Dr. Reddy’s Laboratories enters into c
Dr. Reddy’s Laboratories has entered into a confidential settlement agre..
Financials
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit39945669
Gross Profit 5704 6970
Operating Profit 779715339
Net Sales 2731793593
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
peergroup  7833.20 (0.70%)
M.Cap ( in Cr)16645.00
Divis Lab (BSE)
peergroup  1740.60 (3.03%)
M.Cap ( in Cr)46207.46
Piramal Enterprises (BSE)
peergroup  2585.70 (1.96%)
M.Cap ( in Cr)47838.73
Astrazeneca Pharma I (BSE)
peergroup  2252.50 (1.22%)
M.Cap ( in Cr)5631.25
Indoco Remedies (BSE)
peergroup  217.40 (9.58%)
M.Cap ( in Cr)2003.35
Shareholding Pattern
MUTUAL FUNDS/UTI 9.11%
FI/BANKS/INSURANCE 5.13%
PROMOTERS 26.77%
NON-INSTITUTION 13.66%
GOVERNMENT 0%
FII 0%
About Dr. Reddys Laboratories Ltd.

Dr. Reddys Laboratories Ltd. was incorporated in the year 24-02-1984. Its today's share price is 2816.4. Its current market capitalisation stands at Rs 47417.64 Cr. In the latest quarter, company has reported Gross Sales of Rs. 142810 Cr and Total Income of Rs.144362 Cr. The company's management includes Sandeep Poddar, Bruce L A Carter, Bharat N Doshi, Anupam Puri, GV Prasad, K Satish Reddy, Sridar Iyengar, Prasad R Menon, Omkar Goswami, Kalpana Morparia.

It is listed on the BSE with a BSE Code of 500124 , NSE with an NSE Symbol of DRREDDY and ISIN of INE089A01023. It's Registered office is at 8-2-337, Road No. 3,Banjara Hills,Hyderabad-500034, Telangana. Their Registrars are ACC Ltd. It's auditors are A Rama Chandra Rao & Co, Bharat S Raut & Co, BSR & Co, BSR & Co LLP, SR Batliboi & Associates LLP

Directory

Narnolia Research & Advisory Narnolia Trading Platforms Narnolia Online | media Room